Work

Cost-Effectiveness of Solifenacin for The Treatment of Overactive Bladder From A Us Private Payer and Medicare Advantage Perspective

Year: 2016

Type: article

Source: Value in Health

DOI: 10.1016/j.jval.2016.09.1000

Authors: DB Ng, R Wielage, TM Klein, RW Klein, K Gooch

Institutions: Astellas Pharma (United States), Medical Decision Modeling (United States)

Language: English

Topic: Urinary Bladder and Prostate Research

Subfield: Urology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: bronze

OpenAlex ID: W2544346309

FWCI:

Cites:

Cited by:

Related to: 10